Bone Health Technologies (BHT) is expanding its leadership team with the appointment of Dr. Pamela Peeke as its new Chief Medical Officer and board member, and the addition of Dr. Kian Beyzavi and Marcie Hamilton as new board directors. These appointments reflect BHT’s dedication to advancing the treatment of osteoporosis and osteopenia.
Dr. Kian Beyzavi, who joins BHT’s board of directors, has a PhD in Electrical Engineering/Applied Physics from Princeton University. Dr. Beyzavi has been instrumental in the development of numerous MedTech, Digital Health, and Biopharma products across 60 companies, leveraging dynamic data, AI, and machine learning to drive advances in patient care and provide a system-level view of the healthcare landscape.
Marcie Hamilton, another new board director, brings her expertise in medical devices and consumer products. After earning her B.S. in Mechanical Engineering from Purdue University, Hamilton made significant contributions to VivaRay Inc., leading to its acquisition by Varian Medical Systems. She later co-founded Potrero Medical, which developed a predictive technology platform for early detection of critical illnesses.
Dr. Peeke, an expert in women’s health, menopause, and longevity, is a clinical scientist and Assistant Professor of Medicine at the University of Maryland. She joins BHT as Chief Medical Officer and board member, bringing her expertise in providing a safe, non-pharmacological, clinically-proven solution for individuals with low bone density.
These new appointments will strengthen BHT’s product development, research, and commercial growth, solidifying its position as a leader in treating osteoporosis and osteopenia.
